|
|
Oxidative stress, respiratory muscle dysfunction, and potential therapeutics in chronic obstructive pulmonary disease |
Li ZUO1( ), Allison H. HALLMAN1, Marvin K. YOUSIF1, Michael T. CHIEN2 |
1. Molecular Physiology and Biophysics Laboratory, Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA; 2. Department of Biology, Kalamazoo College, Kalamazoo, MI 49006, USA |
|
|
Abstract Chronic obstructive pulmonary disease (COPD) is a highly relevant disorder that induces respiratory muscle dysfunction. One prevalent symptom of COPD is resistive breathing which causes respiratory muscle to significantly increase the magnitude of contractions, resulting in reactive oxygen species (ROS) formation and oxidative stress. Through cellular signaling cascades, ROS activate molecules such as mitogen-activated protein kinases and nuclear factor-κB. These signaling molecules stimulate the release of cytokines which in turn cause damage to the diaphragm, involving sarcomeric disruptions. In response to COPD induced fatigue, the diaphragm undergoes a beneficial fiber-type shift to type I muscle fibers, which are more resistant to hypoxia than type II fibers. The lung hyperinflation that occurs in COPD also causes intercostal muscle dysfunction, thereby exacerbating COPD symptoms. In addition, COPD is known to have a connection with heart failure, diabetes, and aging, further decreasing respiratory function. Currently, there is no cure for this disorder. Nevertheless, various potential therapeutic strategies focusing on respiratory muscle have been identified including respiratory muscle training, β2-agonist therapy, and lung volume reduction surgery. In this review, we will outline the role of COPD, oxidative stress, and related complications in respiratory muscle dysfunction.
|
Keywords
COPD
diaphragm
ROS
cytokine
respiratory therapy
|
Corresponding Author(s):
ZUO Li,Email:zuo@oakland.edu
|
Issue Date: 01 December 2012
|
|
1 |
ACCP/AACVPR evidence-based guidelines (1997). Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR pulmonary rehabilitation guidelines panel . American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. Chest , 112: 1363–1396
|
2 |
Allen R G, Tresini M (2000). Oxidative stress and gene regulation. Free Radic Biol Med , 28(3): 463–499 doi: 10.1016/S0891-5849(99)00242-7 pmid:10699758
|
3 |
Anthonisen N R, Connett J E, Kiley J P, Altose M D, Bailey W C, Buist A S, Conway W A Jr, Enright P L, Kanner R E, O’Hara P, Owens G R, Scanlon P D, Tashkin D P, Wise R A, Altose M D, Connors A F, Redline S, Deitz C, Rakos R F, Conway W A, DeHorn A, Ward J C, Hoppe-Ryan C S, Jentons R L, Reddick J A, Sawicki C, Wise R A, Permutt S, Rand C S, Scanlon P D, Davis L J, Hurt R D, Miller R D, Williams D E, Caron G M, Lauger G G, Toogood S M, Buist A S, Bjornson W M, Johnson L R, Bailey W C, Brooks C M, Dolce J J, Higgins D M, Johnson M A, Lorish C D, Martin B A, Tashkin D P, Coulson A H, Gong H, Harber P I, Li V C, Roth M, Nides M A, Simmons M S, Zuniga I, Anthonisen N R, Manfreda J, Murray R P, Rempel-Rossum S C, Stoyko J M, Connett J E, Kjelsberg M O, Cowles M K, Durkin D A, Enright P L, Kurnow K J, Lee W W, Lindgren P G, Mongin S J, O’Hara P, Voelker H T, Waller L A, Owens G R, Rogers R M, Johnston J J, Pope F P, Vitale F M, Kanner R E, Rigdon M A, Benton K C, Grant P M, Becklake M, Burrows B, Cleary P, Kimbel P, Nett L, Ockene J K, Senior R M, Snider G L, Spitzer W, Williams O D, Hurd S S, Kiley J P, Wu M C, Ayres S M, Hyatt R E, Mason B A (1994). Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA , 272(19): 1497–1505 doi: 10.1001/jama.1994.03520190043033 pmid:7966841
|
4 |
Armstrong R B (1990). Initial events in exercise-induced muscular injury. Med Sci Sports Exerc , 22(4): 429–435 pmid:2205778
|
5 |
Barreiro E, de la Puente B, Minguella J, Corominas J M, Serrano S, Hussain S N, Gea J (2005). Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 171(10): 1116–1124 doi: 10.1164/rccm.200407-887OC pmid:15735057
|
6 |
Barreiro E, Peinado V I, Galdiz J B, Ferrer E, Marin-Corral J, Sánchez F, Gea J, Barberà J A, the ENIGMA in COPD Project (2010). Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med , 182(4): 477–488 doi: 10.1164/rccm.200908-1220OC pmid:20413628
|
7 |
Begin P, Grassino A (1991). Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis , 143(5 Pt 1): 905–912 pmid:2024841
|
8 |
Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S, Gasparetto A, Lemaire F, Isabey D, Harf A (1995). Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med , 333(13): 817–822 doi: 10.1056/NEJM199509283331301 pmid:7651472
|
9 |
Burge P S, Calverley P M, Jones P W, Spencer S, Anderson J A, Maslen T K (2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ , 320(7245): 1297–1303 doi: 10.1136/bmj.320.7245.1297 pmid:10807619
|
10 |
Cannon J G, St Pierre B A (1998). Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem , 179(1-2): 159–167 doi: 10.1023/A:1006828425418 pmid:9543358
|
11 |
Cavalcante A G, de Bruin P F (2009). The role of oxidative stress in COPD: current concepts and perspectives. J Bras Pneumol , 35(12): 1227–1237 pmid:20126926
|
12 |
Cooper J D, Trulock E P, Triantafillou A N, Patterson G A, Pohl M S, Deloney P A, Sundaresan R S, Roper C L (1995). Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg , 109: 106–116 ; discussion 116–119
|
13 |
Covey M K, Larson J L, Wirtz S E, Berry J K, Pogue N J, Alex C G, Patel M (2001). High-intensity inspiratory muscle training in patients with chronic obstructive pulmonary disease and severely reduced function. J Cardiopulm Rehabil , 21(4): 231–240 doi: 10.1097/00008483-200107000-00008 pmid:11508185
|
14 |
Crisafulli E, Costi S, Fabbri L M, Clini E M (2007). Respiratory muscles training in COPD patients. Int J Chron Obstruct Pulmon Dis , 2(1): 19–25 doi: 10.2147/copd.2007.2.1.19 pmid:18044062
|
15 |
Curkendall S M, DeLuise C, Jones J K, Lanes S, Stang M R, Goehring E Jr, She D (2006). Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol , 16(1): 63–70 doi: 10.1016/j.annepidem.2005.04.008 pmid:16039877
|
16 |
Cutler R G (2005). Oxidative stress and aging: catalase is a longevity determinant enzyme. Rejuvenation Res , 8(3): 138–140 doi: 10.1089/rej.2005.8.138 pmid:16144468
|
17 |
Dal Vecchio L, Polese G, Poggi R, Rossi A (1990). “Intrinsic” positive end-expiratory pressure in stable patients with chronic obstructive pulmonary disease. Eur Respir J , 3(1): 74–80 pmid:2178961
|
18 |
De Troyer A, Kirkwood P A, Wilson T A (2005). Respiratory action of the intercostal muscles. Physiol Rev , 85(2): 717–756 doi: 10.1152/physrev.00007.2004 pmid:15788709
|
19 |
De Troyer A, Wilson T A (2009). Effect of acute inflation on the mechanics of the inspiratory muscles. J Appl Physiol , 107(1): 315–323 doi: 10.1152/japplphysiol.91472.2008 pmid:19265064
|
20 |
Doucet M, Debigaré R, Joanisse D R, C?té C, Leblanc P, Grégoire J, Deslauriers J, Vaillancourt R, Maltais F (2004). Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J , 24(6): 971–979 doi: 10.1183/09031936.04.00020204 pmid:15572541
|
21 |
Eid A A, Ionescu A A, Nixon L S, Lewis-Jenkins V, Matthews S B, Griffiths T L, Shale D J (2001). Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 164(8 Pt 1): 1414–1418 pmid:11704588
|
22 |
Ferguson G T (2006). Why does the lung hyperinflate? Proc Am Thorac Soc , 3(2): 176–179 doi: 10.1513/pats.200508-094DO pmid:16565428
|
23 |
Fessler H E, Permutt S (1998). Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med , 157(3 Pt 1): 715–722 pmid:9517581
|
24 |
Friden J, Sj?str?m M, Ekblom B (1983). Myofibrillar damage following intense eccentric exercise in man. Int J Sports Med , 4(3): 170–176 doi: 10.1055/s-2008-1026030 pmid:6629599
|
25 |
Gea J, Barreiro E (2008). Update on the mechanisms of muscle dysfunction in COPD. Arch Bronconeumol , 44(6): 328–337 doi: 10.1016/S1579-2129(08)60054-3 pmid:18559223
|
26 |
Groneberg D A, Chung K F (2004). Models of chronic obstructive pulmonary disease. Respir Res , 5(1): 18 doi: 10.1186/1465-9921-5-18 pmid:15522115
|
27 |
Guerri R, Gayete A, Balcells E, Ramirez-Sarmiento A, Vollmer I, Garcia-Aymerich J, Gea J, Orozco-Levi M (2010). Mass of intercostal muscles associates with risk of multiple exacerbations in COPD. Respir Med , 104(3): 378–388 doi: 10.1016/j.rmed.2009.10.015 pmid:19932014
|
28 |
Haluszka J, Chartrand D A, Grassino A E, Milic-Emili J (1990). Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis , 141(5 Pt 1): 1194–1197 pmid:2111105
|
29 |
Ito K, Barnes P J (2009). COPD as a disease of accelerated lung aging. Chest , 135(1): 173–180 doi: 10.1378/chest.08-1419 pmid:19136405
|
30 |
Janssens J P, Pache J C, Nicod L P (1999). Physiological changes in respiratory function associated with ageing. Eur Respir J , 13(1): 197–205 doi: 10.1183/09031936.99.14614549 pmid:10836348
|
31 |
Kang M J, Lee C G, Lee J Y, Dela Cruz C S, Chen Z J, Enelow R, Elias J A (2008). Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest , 118(8): 2771–2784 pmid:18654661
|
32 |
Klimathianaki M, Vaporidi K, Georgopoulos D (2011). Respiratory muscle dysfunction in COPD: from muscles to cell. Curr Drug Targets , 12(4): 478–488 doi: 10.2174/138945011794751474 pmid:21194407
|
33 |
Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C (2002). Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol , 26(5): 587–593 pmid:11970911
|
34 |
Lando Y, Boiselle P M, Shade D, Furukawa S, Kuzma A M, Travaline J M, Criner G J (1999). Effect of lung volume reduction surgery on diaphragm length in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 159(3): 796–805 pmid:10051253
|
35 |
Laoutaris I D, Adamopoulos S, Manginas A, Panagiotakos D B, Kallistratos M S, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos D V, Dritsas A (2012). Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol , doi: 10.1016/j.ijcard.2012.05.019
|
36 |
Laude E A, Duffy N C, Baveystock C, Dougill B, Campbell M J, Lawson R, Jones P W, Calverley P M (2006). The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med , 173: 865–870
|
37 |
Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, Dudley G (2002). Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol , 92(3): 1205–1213 pmid:11842060
|
38 |
Levine S, Kaiser L, Leferovich J, Tikunov B (1997). Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med , 337(25): 1799–1806 doi: 10.1056/NEJM199712183372503 pmid:9400036
|
39 |
Loring S H, Garcia-Jacques M, Malhotra A (2009). Pulmonary characteristics in COPD and mechanisms of increased work of breathing. J Appl Physiol , 107(1): 309–314 doi: 10.1152/japplphysiol.00008.2009 pmid:19359620
|
40 |
Lotters F, van Tol B, Kwakkel G, Gosselink R (2002). Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J , 20(3): 570–576 doi: 10.1183/09031936.02.00237402 pmid:12358330
|
41 |
Louvaris Z, Zakynthinos S, Aliverti A, Habazettl H, Vasilopoulou M, Andrianopoulos V, Wagner H, Wagner P, Vogiatzis I (2012). Heliox increases quadriceps muscle oxygen delivery during exercise in COPD patients with and without dynamic hyperinflation. J Appl Physiol , 113(7): 1012–1023 doi: 10.1152/japplphysiol.00481.2012 pmid:22879534
|
42 |
Mador M J (2002). Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 166(6): 787–789 doi: 10.1164/rccm.2206003 pmid:12231484
|
43 |
Mannino D M, Ford E S, Redd S C (2003). Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med , 114(9): 758–762 doi: 10.1016/S0002-9343(03)00185-2 pmid:12829203
|
44 |
Mascarenhas J, Azevedo A, Bettencourt P (2010). Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality. Curr Opin Pulm Med , 16(2): 106–111 doi: 10.1097/MCP.0b013e328335dc90 pmid:20042977
|
45 |
McCullough P A, Hollander J E, Nowak R M, Storrow A B, Duc P, Omland T, McCord J, Herrmann H C, Steg P G, Westheim A, Knudsen C W, Abraham W T, Lamba S, Wu A H, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel A S, Investigators B N P M S, the BNP Multinational Study Investigators (2003). Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med , 10(3): 198–204 doi: 10.1111/j.1553-2712.2003.tb01990.x pmid:12615582
|
46 |
Meecham Jones D J, Paul E A, Jones P W, Wedzicha J A (1995). Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med , 152(2): 538–544 pmid:7633704
|
47 |
Mercadier J J, Schwartz K, Schiaffino S, Wisnewsky C, Ausoni S, Heimburger M, Marrash R, Pariente R, Aubier M (1998). Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol , 274(4 Pt 1): L527–L534 pmid:9575870
|
48 |
Meyer T J, Hill N S (1994). Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med , 120(9): 760–770 pmid:8147550
|
49 |
Mizuno M (1991). Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J , 4(5): 587–601 pmid:1936230
|
50 |
Mohanraj P, Merola A J, Wright V P, Clanton T L (1998). Antioxidants protect rat diaphragmatic muscle function under hypoxic conditions. J Appl Physiol , 84(6): 1960–1966 pmid:9609790
|
51 |
Moon C, Lee Y J, Park H J, Chong Y H, Kang J L (2010). N-acetylcysteine inhibits RhoA and promotes apoptotic cell clearance during intense lung inflammation. Am J Respir Crit Care Med , 181(4): 374–387 doi: 10.1164/rccm.200907-1061OC pmid:19965809
|
52 |
Mroz R M, Szulakowski P, Pierzchala W, Chyczewska E, MacNee W (2006). Pathogenesis of chronic obstructive pulmonary disease. Cellular mechanisms (part I). Wiad Lek , 59(1–2): 92–96 pmid:16646301
|
53 |
Naunheim K S, Wood D E, Mohsenifar Z, Sternberg A L, Criner G J, DeCamp M M, Deschamps C C, Martinez F J, Sciurba F C, Tonascia J, Fishman A P, the National Emphysema Treatment Trial Research Group (2006). Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg , 82(2): 431–443 doi: 10.1016/j.athoracsur.2006.05.069 pmid:16888872
|
54 |
Nava S, Crotti P, Gurrieri G, Fracchia C, Rampulla C (1992). Effect of a beta 2-agonist (broxaterol) on respiratory muscle strength and endurance in patients with COPD with irreversible airway obstruction. Chest , 101(1): 133–140 doi: 10.1378/chest.101.1.133 pmid:1345900
|
55 |
Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas J M, Gea J (2001). Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 164(9): 1734–1739 pmid:11719318
|
56 |
Ottenheijm C A, Heunks L M, Dekhuijzen P N (2007). Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. Am J Respir Crit Care Med , 175(12): 1233–1240 doi: 10.1164/rccm.200701-020PP pmid:17413128
|
57 |
Ottenheijm C A, Heunks L M, Dekhuijzen R P (2008). Diaphragm adaptations in patients with COPD. Respir Res , 9(1): 12 doi: 10.1186/1465-9921-9-12 pmid:18218129
|
58 |
Ottenheijm C A, Heunks L M, Sieck G C, Zhan W Z, Jansen S M, Degens H, de Boo T, Dekhuijzen P N (2005). Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 172(2): 200–205 doi: 10.1164/rccm.200502-262OC pmid:15849324
|
59 |
Pauwels R A, L?fdahl C G, Laitinen L A, Schouten J P, Postma D S, Pride N B, Ohlsson S V, the European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (1999). Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med , 340(25): 1948–1953 doi: 10.1056/NEJM199906243402503 pmid:10379018
|
60 |
Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas D (2002). Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med , 96(8): 594–598 doi: 10.1053/rmed.2002.1322 pmid:12195840
|
61 |
Puente-Maestu L, Pérez-Parra J, Godoy R, Moreno N, Tejedor A, González-Aragoneses F, Bravo J L, Alvarez F V, Cama?o S, Agustí A (2009). Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J , 33(5): 1045–1052 doi: 10.1183/09031936.00112408 pmid:19129279
|
62 |
Ramirez-Sarmiento A, Orozco-Levi M, Guell R, Barreiro E, Hernandez N, Mota S, Sangenis M, Broquetas J M, Casan P, Gea J (2002). Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med , 166(11): 1491–1497 doi: 10.1164/rccm.200202-075OC pmid:12406842
|
63 |
Rana J S, Mittleman M A, Sheikh J, Hu F B, Manson J E, Colditz G A, Speizer F E, Barr R G, Camargo C A Jr (2004). Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care , 27(10): 2478–2484 doi: 10.2337/diacare.27.10.2478 pmid:15451919
|
64 |
Reid M B (2001). Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don’t. J Appl Physiol , 90(2): 724–731 pmid:11160074
|
65 |
Reid M B, Haack K E, Franchek K M, Valberg P A, Kobzik L, West M S (1992). Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol , 73(5): 1797–1804 pmid:1474054
|
66 |
Rennard S I, Vestbo J (2008). Natural histories of chronic obstructive pulmonary disease. Proc Am Thorac Soc , 5(9): 878–883 doi: 10.1513/pats.200804-035QC pmid:19056710
|
67 |
Ribera F, N’Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E (2003). Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 167(6): 873–879 doi: 10.1164/rccm.200206-519OC pmid:12493645
|
68 |
Roisin R R, Vestbo J (2011). Global initiative for chronic obstructive lung disease. GOLD: 1–74
|
69 |
Rutten F H, Cramer M J, Grobbee D E, Sachs A P, Kirkels J H, Lammers J W, Hoes A W (2005). Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J , 26(18): 1887–1894 doi: 10.1093/eurheartj/ehi291 pmid:15860516
|
70 |
Sanchez J, Bastien C, Medrano G, Riquet M, Derenne J P (1984). Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir , 20(6): 535–540 pmid:6440609
|
71 |
Schols A M (2003). Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl , 46: 81s–86s doi: 10.1183/09031936.03.00004611 pmid:14621110
|
72 |
Scott A, Wang X, Road J D, Reid W D (2006). Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations. Eur Respir J , 27(1): 51–59 doi: 10.1183/09031936.06.00143004 pmid:16387935
|
73 |
Shindoh C, DiMarco A, Thomas A, Manubay P, Supinski G (1990). Effect of N-acetylcysteine on diaphragm fatigue. J Appl Physiol , 68(5): 2107–2113 pmid:2361912
|
74 |
Sidney S, Sorel M, Quesenberry C P Jr, DeLuise C, Lanes S, Eisner M D (2005). COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest , 128(4): 2068–2075 doi: 10.1378/chest.128.4.2068 pmid:16236856
|
75 |
Sigala I, Zacharatos P, Toumpanakis D, Michailidou T, Noussia O, Theocharis S, Roussos C, Papapetropoulos A, Vassilakopoulos T (2011). MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress. Am J Physiol Regul Integr Comp Physiol , 300(5): R1152–R1162 doi: 10.1152/ajpregu.00376.2010 pmid:21325641
|
76 |
Smith W N, Dirks A, Sugiura T, Muller S, Scarpace P, Powers S K (2002). Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment. J Appl Physiol , 92(3): 941–948 pmid:11842024
|
77 |
Son Y O, Wang L, Poyil P, Budhraja A, Hitron J A, Zhang Z, Lee J C, Shi X (2012). Cadmium induces carcinogenesis in BEAS-2b cells through ROS-dependent activation of PI3K/AKT/GSK-3beta/beta-catenin signaling. Toxicol Appl Pharmacol , doi: S0041–008X(12)00329–8 [pii] 10.1016/j.taap.2012.07.028
|
78 |
Stauber W T, Smith C A, Miller G R, Stauber F D (2000). Recovery from 6 weeks of repeated strain injury to rat soleus muscles. Muscle Nerve , 23(12): 1819–1825 doi: 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2 pmid:11102904
|
79 |
Stubbings A K, Moore A J, Dusmet M, Goldstraw P, West T G, Polkey M I, Ferenczi M A (2008). Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease. J Physiol , 586(10): 2637–2650 doi: 10.1113/jphysiol.2007.149799 pmid:18372305
|
80 |
Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G (2010). Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J , 35(3): 549–556 doi: 10.1183/09031936.00091108 pmid:19717478
|
81 |
Tidball J G (2005). Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol , 288(2): R345–R353 doi: 10.1152/ajpregu.00454.2004 pmid:15637171
|
82 |
Van Der Heijden H F, Dekhuijzen P N, Folgering H, Ginsel L A, Van Herwaarden C L (1998). Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters. J Appl Physiol , 85(1): 215–222 pmid:9655778
|
83 |
Vestbo J, S?rensen T, Lange P, Brix A, Torre P, Viskum K (1999). Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet , 353(9167): 1819–1823 doi: 10.1016/S0140-6736(98)10019-3 pmid:10359405
|
84 |
Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, Magnussen H (2010). Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest , 138(1): 32–38 pmid:20190002
|
85 |
Wijnhoven H J, Heunks L M, Geraedts M C, Hafmans T, Vi?a J R, Dekhuijzen P N (2006). Oxidative and nitrosative stress in the diaphragm of patients with COPD. Int J Chron Obstruct Pulmon Dis , 1(2): 173–179 doi: 10.2147/copd.2006.1.2.173 pmid:18046894
|
86 |
Willems M E, Stauber W T (2001). Force deficits after repeated stretches of activated skeletal muscles in female and male rats. Acta Physiol Scand , 172(1): 63–67 doi: 10.1046/j.1365-201X.2001.00808.x pmid:11437740
|
87 |
Wouters E F (2000). Nutrition and metabolism in COPD. Chest , 117(5 Suppl 1): 274S–280S doi: 10.1378/chest.117.5_suppl_1.274S pmid:10843949
|
88 |
Zuo L, Nogueira L, Hogan M C (2011a). Reactive oxygen species formation during tetanic contractions in single isolated Xenopus myofibers. J Appl Physiol , 111(3): 898–904 doi: 10.1152/japplphysiol.00398.2011 pmid:21700897
|
89 |
Zuo L, Roberts W J, Tolomello R C, Goins A T (2011b). Ischemic and hypoxic preconditioning protect cardiac muscles via intracellular ROS signaling. Front Biol , doi: 10.1007/s11515-012-1225-z
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|